Mirion Technologies, Inc.

Good day, everyone.

My name is Megan, and I will be your conference operator today. At this time, I would like to welcome you to the Merion third quarter 2026 earnings call. All lines in the place on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time and you have joined via the webinar, please use the raise hand icon, which can be found at the bottom of your webinar application. At this time, I would like to turn the call over to Eric Linn, head of investor relations and treasurer.

Thank you and good morning. Welcome to Murion's third quarter 2026 earnings conference call. Joining me this morning are Murion's founder, chairman and CEO, Tom Logan, and Murion's CFO and medical group president, Brian Schopfer. Before we begin today's prepared remarks, allow me to remind you that comments made during this call will include forward-looking statements and actual results may differ materially from those projected in the forward-looking statements. The factors that could cause actual results to differ are discussed in our annual reports on Form 10-K, quarterly reports on Form 10-Q, and in Miriam's other SEC filings under the caption Risk Factors. Quarterly references within today's discussion are related to the third quarter ended September 30, 2026, unless otherwise noted. The comments made during this call will also include certain financial measures that were not prepared in accordance with generally accepted accounting principles. Reconciliation of those non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the appendix of the presentation accompanying today's call. All earnings materials can be found in the investor relations section of our website at www.merion.com. With that, let me now turn the call over to Tom, who will begin on panel three.